{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:04:46Z","timestamp":1792015486453,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Multiple Sclerosis Research Center to support this project","award":["grant number 1400-1-148-52617"],"award-info":[{"award-number":["grant number 1400-1-148-52617"]}]},{"name":"Multiple Sclerosis Research Center to support this project","award":["grant number 1400-1-148-52617"],"award-info":[{"award-number":["grant number 1400-1-148-52617"]}]},{"name":"Research Institute for Oncology, Hematology& Cell Therapy Facility, Shariati Hospital","award":["grant number 1400-1-233-51589 ."],"award-info":[{"award-number":["grant number 1400-1-233-51589 ."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09372-1","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T10:01:43Z","timestamp":1711706503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Good manufacturing practices production of human placental derived mesenchymal stem cells for therapeutic applications: focus on multiple sclerosis"],"prefix":"10.1007","volume":"51","author":[{"given":"Ameneh","family":"Shokati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8598-0911","authenticated-orcid":false,"given":"Abdorreza","family":"Naser Moghadasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andisheh","family":"Ghashghaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Sahraian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Chahardouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Asadollah","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5083-2081","authenticated-orcid":false,"given":"Jafar","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6621-5424","authenticated-orcid":false,"given":"Mohsen","family":"Nikbakht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,29]]},"reference":[{"key":"9372_CR1","doi-asserted-by":"publisher","first-page":"2495848","DOI":"10.1155\/2018\/2495848","volume":"2018","author":"K Dzobo","year":"2018","unstructured":"Dzobo K, Thomford NE, Senthebane DA, Shipanga H, Rowe A, Dandara C, Pillay M, Motaung K (2018) Advances in regenerative medicine and tissue engineering: innovation and transformation of medicine. Stem Cells Int 2018:2495848","journal-title":"Stem Cells Int"},{"key":"9372_CR2","first-page":"1","volume":"11","author":"G Shroff","year":"2018","unstructured":"Shroff G (2018) A review on stem cell therapy for multiple sclerosis: special focus on human embryonic stem cells. Stem Cells Cloning Adv Appl 11:1\u201311","journal-title":"Stem Cells Cloning Adv Appl"},{"issue":"1","key":"9372_CR3","first-page":"1","volume":"19","author":"N Ghasemi","year":"2017","unstructured":"Ghasemi N, Razavi S, Nikzad E (2017) Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J 19(1):1\u201310","journal-title":"Cell J"},{"issue":"1","key":"9372_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, Rocca MA (2018) Multiple sclerosis. Nat Rev Dis Primers 4(1):43","journal-title":"Nat Rev Dis Primers"},{"key":"9372_CR5","doi-asserted-by":"crossref","unstructured":"Mares J, Hartung H-P: Multiple sclerosis and COVID-19. 2020, 164(3):217\u2013225.","DOI":"10.5507\/bp.2020.033"},{"issue":"2","key":"9372_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/biomedicines7020026","volume":"7","author":"F Cuascut","year":"2019","unstructured":"Cuascut F, Hutton G (2019) Stem cell-based therapies for multiple sclerosis: current perspectives. Biomedicines 7(2):26\u201326","journal-title":"Biomedicines"},{"issue":"1","key":"9372_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s13311-012-0162-5","volume":"10","author":"HL Atkins","year":"2013","unstructured":"Atkins HL, Freedman MS (2013) Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned. Neurotherapeutics 10(1):68\u201376","journal-title":"Neurotherapeutics"},{"issue":"1","key":"9372_CR8","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s13287-021-02477-5","volume":"12","author":"A Shokati","year":"2021","unstructured":"Shokati A, Naser Moghadasi A, Nikbakht M, Sahraian MA, Mousavi SA, Ai J (2021) A focus on allogeneic mesenchymal stromal cells as a versatile therapeutic tool for treating multiple sclerosis. Stem Cell Res Ther 12(1):400","journal-title":"Stem Cell Res Ther"},{"key":"9372_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/7651_2020_282","volume":"2286","author":"HR Aghayan","year":"2021","unstructured":"Aghayan HR, Payab M, Mohamadi-Jahani F, Aghayan SS, Larijani B, Arjmand B (2021) GMP-compliant production of human placenta-derived mesenchymal stem cells. Methods Mol Biol 2286:213\u2013225","journal-title":"Methods Mol Biol"},{"key":"9372_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/7651_2020_281","volume":"2286","author":"S Ebrahimi-Barough","year":"2021","unstructured":"Ebrahimi-Barough S, Ai J, Payab M, Alavi-Moghadam S, Shokati A, Aghayan HR, Larijani B, Arjmand B (2021) Standard operating procedure for the good manufacturing practice-compliant production of human endometrial stem cells for multiple sclerosis. Methods Mol Biol 2286:199\u2013212","journal-title":"Methods Mol Biol"},{"issue":"9","key":"9372_CR11","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.jcyt.2016.06.002","volume":"18","author":"AO Selim","year":"2016","unstructured":"Selim AO, Selim SA, Shalaby SM, Mosaad H, Saber T (2016) Neuroprotective effects of placenta-derived mesenchymal stromal cells in a rat model of experimental autoimmune encephalomyelitis. Cytotherapy 18(9):1100\u20131113","journal-title":"Cytotherapy"},{"issue":"6","key":"9372_CR12","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.msard.2014.08.002","volume":"3","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Bowen JD, Huddlestone J, Kremenchutzky M, Carpenter A, Corboy JR, Freedman MS, Krupp L, Paulo C, Hariri RJ et al (2014) Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study. Mult Scler Relat Disord 3(6):696\u2013704","journal-title":"Mult Scler Relat Disord"},{"key":"9372_CR13","volume-title":"Screening donated blood for transfusion-transmissible infections: recommendations","author":"World Health Organization","year":"2010","unstructured":"World Health Organization (2010) Screening donated blood for transfusion-transmissible infections: recommendations. World Health Organization, Geneva"},{"issue":"3","key":"9372_CR14","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jcyt.2012.09.006","volume":"15","author":"M Abou-El-Enein","year":"2013","unstructured":"Abou-El-Enein M, R\u00f6mhild A, Kaiser D, Beier C, Bauer G, Volk H-D, Reinke P (2013) Good manufacturing practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs. Cytotherapy 15(3):362\u2013383","journal-title":"Cytotherapy"},{"issue":"3","key":"9372_CR15","first-page":"243","volume":"2","author":"R Giancola","year":"2012","unstructured":"Giancola R, Bonfini T, Iacone A (2012) Cell therapy: cGMP facilities and manufacturing. Muscles Ligaments Tendons J 2(3):243\u2013247","journal-title":"Muscles Ligaments Tendons J"},{"key":"9372_CR16","first-page":"1","volume-title":"Cell culture techniques","author":"A Bal-Price","year":"2011","unstructured":"Bal-Price A, Coecke S (2011) Guidance on good cell culture practice (GCCP). In: Aschner M, Su\u00f1ol C, Bal-Price A (eds) Cell culture techniques. Humana, Totowa, NJ, pp 1\u201325"},{"issue":"1","key":"9372_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.imr.2016.12.001","volume":"6","author":"TH Jang","year":"2017","unstructured":"Jang TH, Park SC, Yang JH, Kim JY, Seok JH, Park US, Choi CW, Lee SR, Han J (2017) Cryopreservation and its clinical applications. Integr Med Res 6(1):12\u201318","journal-title":"Integr Med Res"},{"issue":"4","key":"9372_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315\u2013317","journal-title":"Cytotherapy"},{"key":"9372_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-1-60761-999-4_3","volume":"698","author":"P Horn","year":"2011","unstructured":"Horn P, Bork S, Wagner W (2011) Standardized isolation of human mesenchymal stromal cells with red blood cell lysis. Methods Mol Biol 698:23\u201335","journal-title":"Methods Mol Biol"},{"key":"9372_CR20","first-page":"83","volume":"2","author":"F Aj","year":"1974","unstructured":"Aj F (1974) Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2:83\u201392","journal-title":"Exp Hematol"},{"key":"9372_CR21","doi-asserted-by":"crossref","unstructured":"Pelekanos RA, Sardesai VS, Futrega K, Lott WB, Kuhn M, Doran MR (2016) Isolation and expansion of mesenchymal stem\/stromal cells derived from human placenta tissue. J Vis Exp (112):54204","DOI":"10.3791\/54204"},{"issue":"6","key":"9372_CR22","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1089\/scd.2007.0154","volume":"17","author":"S Barlow","year":"2008","unstructured":"Barlow S, Brooke G, Chatterjee K, Price G, Pelekanos R, Rossetti T, Doody M, Venter D, Pain S, Gilshenan K (2008) Comparison of human placenta-and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev 17(6):1095\u20131108","journal-title":"Stem Cells Dev"},{"issue":"Suppl 2","key":"9372_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2174\/1874325001105010253","volume":"5","author":"P Mafi","year":"2011","unstructured":"Mafi P, Hindocha S, Mafi R, Griffin M, Khan WS (2011) Adult mesenchymal stem cells and cell surface characterization\u2014a systematic review of the literature. Open Orthop J 5(Suppl 2):253\u2013260","journal-title":"Open Orthop J"},{"issue":"1","key":"9372_CR24","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1186\/s12864-016-3230-0","volume":"17","author":"B Roson-Burgo","year":"2016","unstructured":"Roson-Burgo B, Sanchez-Guijo F, Del Ca\u00f1izo C, De Las RJ (2016) Insights into the human mesenchymal stromal\/stem cell identity through integrative transcriptomic profiling. BMC Genomics 17(1):944","journal-title":"BMC Genomics"},{"issue":"2","key":"9372_CR25","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1634\/stemcells.2007-0594","volume":"26","author":"O Parolini","year":"2008","unstructured":"Parolini O, Alviano F, Bagnara GP, Bilic G, B\u00fchring H-J, Evangelista M, Hennerbichler S, Liu B, Magatti M, Mao N et al (2008) Concise review: Isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells. Stem Cells 26(2):300\u2013311","journal-title":"Stem Cells"},{"issue":"3","key":"9372_CR26","first-page":"161","volume":"10","author":"S Mohammadi","year":"2016","unstructured":"Mohammadi S, Nikbakht M, Mohammadi AM, Panah MZ, Ostadali MR, Nasiri H, Ghavamzadeh A (2016) Human platelet lysate as a xeno free alternative of fetal bovine serum for the in vitro expansion of human mesenchymal stromal cells. Int J Hematol Oncol Stem Cell Res 10(3):161","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"7","key":"9372_CR27","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1002\/bit.24425","volume":"109","author":"NE Timmins","year":"2012","unstructured":"Timmins NE, Kiel M, G\u00fcnther M, Heazlewood C, Doran MR, Brooke G, Atkinson K (2012) Closed system isolation and scalable expansion of human placental mesenchymal stem cells. Biotechnol Bioeng 109(7):1817\u20131826","journal-title":"Biotechnol Bioeng"},{"issue":"3","key":"9372_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4161\/org.5.3.9811","volume":"5","author":"S Thirumala","year":"2009","unstructured":"Thirumala S, Goebel WS, Woods EJ (2009) Clinical grade adult stem cell banking. Organogenesis 5(3):143\u2013154","journal-title":"Organogenesis"},{"issue":"5","key":"9372_CR29","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3109\/14653249.2010.544721","volume":"13","author":"PP Carvalho","year":"2011","unstructured":"Carvalho PP, Wu X, Yu G, Dietrich M, Dias IR, Gomes ME, Reis RL, Gimble JM (2011) Use of animal protein-free products for passaging adherent human adipose-derived stromal\/stem cells. Cytotherapy 13(5):594\u2013597","journal-title":"Cytotherapy"},{"issue":"4","key":"9372_CR30","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000141567","volume":"35","author":"K Bieback","year":"2008","unstructured":"Bieback K, Schallmoser K, Kl\u00fcter H, Strunk D (2008) Clinical protocols for the isolation and expansion of mesenchymal stromal cells. Transfus Med Hemother 35(4):286\u2013294","journal-title":"Transfus Med Hemother"},{"key":"9372_CR31","doi-asserted-by":"publisher","first-page":"236","DOI":"10.5581\/1516-8484.20120057","volume":"34","author":"EJ Sekiya","year":"2012","unstructured":"Sekiya EJ, Forte A, K\u00fchn TIBdB, Janz F, Bydlowski SP, Alves A (2012) Establishing a stem cell culture laboratory for clinical trials. Rev Bras Hematol Hemoter 34:236\u2013241","journal-title":"Rev Bras Hematol Hemoter"},{"key":"9372_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13287-015-0272-1","volume":"7","author":"MM Bakhuraysah","year":"2016","unstructured":"Bakhuraysah MM, Siatskas C, Petratos S (2016) Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality? Stem Cell Res Ther 7:12","journal-title":"Stem Cell Res Ther"},{"key":"9372_CR33","first-page":"1","volume-title":"Cell engineering and regeneration","author":"JP Acker","year":"2020","unstructured":"Acker JP, Bondarovych M, Brunotte R, Buriak IA, Fuller BJ, Glasmacher B, Goltsev AM, Gregor J, Gryshkov O, Herrity K et al (2020) Preservation and storage of cells for therapy: current applications and protocols. In: Gimble JM, Marolt Presen D, Oreffo ROC, Wolbank S, Redl H (eds) Cell engineering and regeneration. Springer International Publishing, Cham, pp 1\u201369"},{"issue":"1","key":"9372_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jcyt.2014.06.008","volume":"17","author":"K Pollock","year":"2015","unstructured":"Pollock K, Sumstad D, Kadidlo D, McKenna DH, Hubel A (2015) Clinical mesenchymal stromal cell products undergo functional changes in response to freezing. Cytotherapy 17(1):38\u201345","journal-title":"Cytotherapy"},{"issue":"4","key":"9372_CR35","first-page":"544","volume":"20","author":"H Alsalim","year":"2019","unstructured":"Alsalim H, Jafarpour F, Ghazvini Zadegan F, Nasr-Esfahani MH, Niasari-Naslaji A (2019) Epigenotoxic effect of dimethyl sulfoxide on buffalo somatic cells and buffalo-bovine interspecies somatic cell nuclear transfer embryos. Cell J 20(4):544\u2013551","journal-title":"Cell J"},{"issue":"3","key":"9372_CR36","first-page":"199","volume":"47","author":"IHT Guideline","year":"2001","unstructured":"IHT Guideline (2001) Guideline for good clinical practice. J Postgrad Med 47(3):199\u2013203","journal-title":"J Postgrad Med"},{"issue":"2","key":"9372_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/scrt436","volume":"5","author":"Y Zhu","year":"2014","unstructured":"Zhu Y, Yang Y, Zhang Y, Hao G, Liu T, Wang L, Yang T, Wang Q, Zhang G, Wei J (2014) Placental mesenchymal stem cells of fetal and maternal origins demonstrate different therapeutic potentials. Stem Cell Res Ther 5(2):1\u201310","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"9372_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.7599\/hmr.2015.35.4.207","volume":"35","author":"GJ Kim","year":"2015","unstructured":"Kim GJ (2015) Advanced research on stem cell therapy for hepatic diseases: potential implications of a placenta-derived mesenchymal stem cell-based strategy. Hanyang Medical Reviews 35(4):207\u2013207","journal-title":"Hanyang Medical Reviews"},{"issue":"9","key":"9372_CR39","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1586\/ern.11.113","volume":"11","author":"PJ Darlington","year":"2011","unstructured":"Darlington PJ, Boivin M-N, Bar-Or A (2011) Harnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosis. Expert Rev Neurother 11(9):1295\u20131303","journal-title":"Expert Rev Neurother"},{"issue":"6","key":"9372_CR40","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/s41423-020-00618-z","volume":"18","author":"MJ Mansilla","year":"2021","unstructured":"Mansilla MJ, Presas-Rodr\u00edguez S, Teniente-Serra A, Gonz\u00e1lez-Larreategui I, Quirant-S\u00e1nchez B, Fondelli F, Djedovic N, Iwaszkiewicz-Grze\u015b D, Chwojnicki K, Miljkovi\u0107 \u0110 et al (2021) Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy. Cell Mol Immunol 18(6):1353\u20131374","journal-title":"Cell Mol Immunol"},{"key":"9372_CR41","first-page":"670","volume":"1","author":"PS Pandey","year":"2022","unstructured":"Pandey PS, Kant S, Shukla V, Mavi AK (2022) Therapeutic use of mesenchymal stem cells against SARS-Cov-2: present and future prospects. Curr Med 1:670","journal-title":"Curr Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09372-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09372-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09372-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T20:31:44Z","timestamp":1738701104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09372-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9372"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09372-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,29]]},"assertion":[{"value":"5 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interests exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted according to national ethical standards and laws and have been endorsed by the Ethics Committee at Tehran university of Medical Sciences (Ref # IR.TUMS.HORCSCT.REC.1400.007).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the donors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"460"}}